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Abstract 
There have been many studies on glass particle contamination from glass ampules during the injection of glass 
ampules, but only the contamination from direct IV bolus injection has been measured. This research aimed to study 
the difference in glass particle contamination from ampules with different intravenous administration methods 
commonly used in clinical practice. Four methods were studied: IV bolus injection directly after immediate aspira‑
tion, IV bolus injection directly after 2 min’ delayed aspiration, IV bolus injection directly after aspiration with a filter 
needle, and side shooting to an infusion set with an in‑line filter. 45 ampules per method for a total of 180 ampules 
were used. The number and length of glass particles were measured using a slide scanner. Aspiration was performed 
without specifically using a slow aspiration method. The longest glass particle was observed in the immediate aspira‑
tion group. The side shooting group showed the lowest maximum number of glass particles per ampule. The side 
shooting group also showed the smallest number of glass particles, but it was statistically insignificant. Using a filter 
needle syringe and 2 min’ delayed aspiration, which are frequently recommended to minimize contamination, may 
not be as effective as commonly believed, unless combined with a slow and low pressure aspiration method. Using 
a side shooting to an infusion set with an in‑line filter may minimize glass particle contamination from ampules even 
without a slow and low pressure aspiration method, but more evidence from a larger study is needed.
© 2016 Joo et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided 
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate 
if changes were made.
Background
Medication is an important and basic duty for health 
care professionals. It is the responsibility of a nurse to 
administrate drugs safely and accurately to the patient. 
Many drugs are manufactured as a glass ampule due to 
its sterility and portability, and often premeasured as a 
single dose. However, glass particles may be introduced 
during the manufacturing, opening, and injection of 
glass ampules (Caudron et al. 2011). These particles can 
cause various harmful side effects when they circulate 
in the body. Injected glass particles can travel through 
the blood vessels to arrive at various organs, and cause 
inflammatory responses. They are known to cause block-
ages, embolism, tissue necrosis, and sepsis (Brewer and 
Dunning 1947; Shaw and Lyall 1985; Carbone-Traber 
and Shanks 1986; Preston and Hegadoren 2004). In spite 
of these risks, glass ampules are commonly used for 
injections.
There are several strategies to decrease glass particle 
contamination when using glass ampules. Filter nee-
dle syringes have been introduced into practice and are 
recommended for special patient care, such as neonatal 
patient care to maximize patient safety (Heiss-Harris and 
Verklan 2005). The use of prefilled syringe drugs may also 
be a useful method to prevent glass particle contami-
nation in peripheral intravenous admixtures (Yorioka 
et al. 2006). It has been recommended that wiping glass 
ampules with alcohol before opening should be a routine 
part of neuraxial anaesthesia to reduce the contamination 
of glass ampules (Hemingway et al. 2007). Glass or inor-
ganic particulate contaminants may be reduced by open-
ing glass ampules using a vacuum machine, especially 
small-sized particles which may not be removed with 
membrane filters (Lee et al. 2011). The American Society 
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of Health-system Pharmacists (ASHP) guidelines rec-
ommend that 5 µm filter straws or filter needles be used 
when aspirating the contents of ampules to minimize 
particulate contamination (ASHP guidelines on com-
pounding sterile preparations 2014). The policies regard-
ing the use of filter needles vary between institutions and 
countries, and filter needles are often not used because 
they are expensive and cumbersome. There have been 
many prior studies of glass particle contamination dur-
ing the opening of glass ampules. The main focus of these 
studies was the side effect of glass particles in the body 
or the degree of glass particle contamination. The degree 
of glass ampule particle contamination has been stud-
ied based on the ampule size and the opening method of 
glass ampules, the size of injection needles, and the use 
of filters (Caudron et al. 2011; Shaw and Lyall 1985; Car-
bone-Traber and Shanks 1986; Preston and Hegadoren 
2004; Heiss-Harris and Verklan 2005; Turco and Davis 
1972; Purdie and Punchihewa 1982; Pinnock 1984).
Prior studies used a microscope to measure glass parti-
cles in a slide or a paper sampled from a syringe aspirated 
from opened glass ampules. These studies estimated glass 
particles introduced into the body when a single dose of 
a glass ampule is injected directly. However, there are 
other commonly used methods to inject drugs into the 
vein, such as direct IV bolus injection, side shooting into 
the Y-shape injection port of the infusion set with in-line 
filter, and infusion after mixing the drug with other IV 
solutions, as well as using an intermittent infusion device 
such as injection adapter caps. For inpatients, side shoot-
ing using a Y-shape infusion set or infusion after mixing 
the drug with other IV solution is more frequently used 
than direct IV bolus injection. Y-shape infusion sets for 
side shooting commonly contain a 15 µm filter at the end 
of the set, but filters of various sizes are used in different 
hospitals and departments. Some counties recommend 
aspirating drugs 1–2  min after opening a glass ampule 
to settle down glass particles [The Korea Food and Drug 
Administration (KFDA) 2010].
However, there have been few studies to verify the 
effectiveness and feasibility of these methods in clinical 
practice. This study compares the difference in glass par-
ticle contamination from ampules with different intrave-
nous administration methods used in clinical practice.
Methods
Research design
The study was a descriptive observational study which 
collected, measured, and analyzed the degree of glass 
particle contamination from glass ampules with different 
intravenous injection methods. Four injection methods 
were used in this study: IV bolus injection directly after 
immediate aspiration, IV bolus injection directly after 
2 min’ delayed aspiration, IV bolus injection directly after 
aspiration with a filter needle syringe, and side shooting 
to an infusion set with an in-line filter.
Sample
A total of 45 ampules per injection method resulting in a 
total of 180 ampules were opened and analyzed for this 
study.
45 ampules per injection method were chosen by the 
distribution analysis of medium effect size of 0.25, level 
of significance of 0.05, and statistical power of 0.80 with 
the G* Power 3.0 program. Glass ampules of 2 mL ascor-
bic acid were used from a single manufacturer.
Materials used
1. Syringe
 Unfiltered and filtered 3  ml syringes with 23G nee-
dles were used. The filter pore size of the filtered nee-
dles was 5 μm.
2. Infusion set
 A general Y-shaped infusion set with a 15  μm pore 
in-line filter attached at the end of the set was used. 
The ampule contents were injected through the prox-
imal Y-shaped connection (Fig. 1).
3. Micro centrifuge
 A high speed micro centrifuge (Micro 12, Hanil Sci-
ence Industrial, Incheon, Korea) was used for the 
research.
4. Slide Scanner
 A slide scanner (Pannoramic MIDI, 3DHISTECH 
Ltd., Budapest, Hungry) with an attached camera 
with manually adjustable magnifying power and 
auto focus capabilities (Allied Vision Technologies, 
Stadtroda, Germany) was used.
5. Others
 Other materials used for the research were dispos-
able alcohol swabs, microscope slides, microscope 
cover glasses, wipers, micropipette, sterilized pipette 
tips, and sterilized microtubes.
Procedure
1. Opening of the ampule
 After the neck of the ampule was cleaned with dis-
posable alcohol swabs twice, the ampule was opened 
by breaking the neck along the scored line with an 
outward snapping motion.
2. Aspiration of the ampule
 The ampule was aspirated by inserting a needle into 
the ampule slowly and carefully to avoid touching the 
edge of the ampule opening. The ampule was com-
pletely aspirated (2 mL) by tilting the ampule gradu-
ally to accumulate the drug at the lower portion of 
the ampule. Aspiration was performed without spe-
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cifically using a slow aspiration method by a nurse 
with over 10 years of clinical experience.
3. Group assignment
 Ampules were assigned to one of the following four 
groups randomly by the random number generation 
function of Microsoft Excel:
• IV bolus injection directly after immediate aspira-
tion group (group 1):
Aspirated with an unfiltered syringe immediately 
after opening an ampule.
•  IV bolus injection directly after 2 min’ delayed aspi-
ration group (group 2):
Aspirated with an unfiltered syringe 2  min after 
opening a glass ampule to allow glass particles to 
settle onto the bottom of an ampule.
•  IV bolus injection directly after aspiration with a fil-
ter needle syringe group (group 3):
Aspirated with a filter needle syringe immediately 
after opening an ampule.
•  Side shooting to an infusion set with an in-line filter 
group (group 4):
Injected at the Y-shape injection port of an infusion 
sets (side shooting) following aspiration immedi-
ately after opening an ampule.
4. Slide preparation
 Aspirated drug from each ampule was injected into 
a sterilized microtube, and high speed centrifugation 
was performed to precipitate glass particles to the 
bottom of the microtube. They were each sampled by 
20 µL, using a micropipette and disposal pipette tips. 
The 20 µL sample which contained glass particles 
was infused onto a slide glass and covered by a cover 
glass.
5. Scanning of slides
 One slide per ampule was made resulting in a total 
of 180 slides and the slides were scanned by a slide 
scanner to obtain magnified images. Suitable range 
of magnifying power was obtained by using the man-
ually-adjustable magnifying power capability of the 
camera, and then the slides were scanned by using 
the auto-focus capability of the camera.
6. Measuring of glass particles
 Images obtained by the scanner were analyzed by 
a specialized slide viewing software (Pannoramic 
Viewer, version 1.15). The length of glass particles in 
a randomly selected area (6000  µm  ×  6000  µm) of 
each slide was measured by electronic calipers and 
the number of glass particles of each length range 
was tabulated (Fig. 2). They were grouped into nine 
groups according to the length of glass particle (≤5, 
5–10, 10–15, 15–50, 50–100, 100–150, 150–200, 
200–300, and  >300  µm). This was because the pore 
diameter in a filter needle syringe was 5  µm, the 
diameter of a pulmonary capillary was 10  µm, and 
the pore diameter of an in-line filter at the end of an 
infusion set was 15 µm.
Data analysis
The collected data was analyzed by using the statisti-
cal program SPSS version 19.0. The differences of the 
four intravenous injection methods were measured by 
Kruskal–Wallis test and χ2-test after log transformation 
of the number and the length of glass particles.
Fig. 1 Infusion set with an in‑line filter. Figure shows a general Y shaped infusion set. After injection into the Y shaped connection, the injection 
fluid flows through a 15 μm pore in‑line filter at the distal end (magnified circle in figure)
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Ethical considerations
The research was reviewed and authorized by the Insti-
tutional Review Board (IRB No: MC12QISI0177). Before 
collecting and analyzing the materials, the researcher was 
trained at the Integrative Research Support Center for 
the operation of micro centrifuge, slide scanner and slide 
viewing software. During the training, the researcher 
conducted more than 10 pilot tests including slide 
preparation, scanning the slide and measuring of glass 
particles.
Results
Number of glass particles with different intravenous 
injection methods
The total number of glass particles in the 180 glass 
ampules tested was 19,473. The number of glass parti-
cles in each glass ampule was between 15 and 419 par-
ticles and the average number of glass particles in each 
glass ampule was 108.18  ±  79.45. Among 19,473 glass 
particles in 180 glass ampules tested, there were 5169 
glass particles in group 1 (immediate aspiration), 5311 
glass particles in group 2 (2 min delay), 4971 glass parti-
cles in group 3 (filtered needle), and 4022 glass particles 
in group 4 (side shooting). The number of glass particles 
was the smallest in group 4 (side shooting), but the dif-
ferences were not statistically significant. There were 
glass ampules containing more than 400 glass particles 
in group 1 (immediate aspiration) and group 2 (2  min 
delay), while all ampules in group 4 (side shooting) con-
tained less than or equal to 220 glass particles (Table 1, 
Fig. 3).
Ampules were grouped by the number of glass par-
ticles contaminated; less than 50, between 51 and 100, 
between 101 and 150, between 151 and 200, between 201 
and 300, and more than 301 glass particles. The num-
ber of ampules by the number of glass particles between 
groups did not show a statistically significant difference 
(Table  2). The number of ampules with more than 100 
glass particles was the smallest in group 4 (side shooting).
Fig. 2 Image from the slide scanner of aspirated fluid from group 1 (immediate aspiration), showing a large glass particle magnified (long arrow) 
with several smaller glass particles (short arrows)
Table 1 Number of glass particles per ampule (n = 180)
Group 1 IV bolus injection directly after immediate aspiration, Group 2 IV bolus 
injection directly after 2 min’ delayed aspiration, Group 3 IV bolus injection 
directly after aspiration with a filter needle syringe and Group 4 Side shooting to 
an infusion set with an in-line filter
Group Number χ2 p
Mean ± SD Median Range
1 (n = 45) 114.87 ± 89.26 78.00 17–419 0.647 0.886
2 (n = 45) 118.02 ± 90.60 87.00 15–410
3 (n = 45) 110.47 ± 81.58 85.00 16–338
4 (n = 45) 89.38 ± 48.35 80.00 18–220
Total 108.18 ± 79.45 83.50 15–419
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Length of glass particles with different intravenous 
injection methods
The average length of glass particles was 
21.38 ± 17.06 µm and the range of glass particle length 
was between 1.92 and 504.67 µm. The longest glass parti-
cle was observed in group 1 (immediate aspiration). Glass 
particles longer than 300  µm were observed in group 1 
(immediate aspiration), but all glass particles in group 4 
(side shooting) were shorter than 191 µm (Table 3; Fig. 4).
The number of glass particles longer than 10 µm, longer 
than 50 µm, and longer than 100 µm were 70.4, 3.8 and 
0.4  %, respectively. There was a significant difference in 
the number of particles when grouping by the length of 
glass particles between the different intravenous injection 
methods (Table  4). Glass particles longer than 150  µm 
were observed less in group 3 (filtered needle) and group 
4 (side shooting).
Discussion
This study analyzed the contamination of glass particles 
with different intravenous injection methods commonly 
used in clinical practice. For inpatients, an intravenous 
injection using a side shooting to an infusion set is more 
frequently used than a direct IV bolus injection, but prior 
studies analyzed the contamination of glass particles 
using only the direct IV bolus injection method. The filter 
needle syringe method is recommended for use in inten-
sive care units and patients that are severely ill, such as 
infants, cancer patients, and major surgical patients. This 
study also included the 2 min’ delayed aspiration method 
since the guideline of some countries recommended the 
2  min’ delayed aspiration method [The Korea Food and 
Drug Administration (KFDA) 2010].
The number of glass particles was the smallest in group 
4 (side shooting), but it was not statistically significant. 
This is different from the results of prior studies which 
suggested that the number of glass particles was reduced 
significantly with an in-line filter (Shaw and Lyall 1985; 
Preston and Hegadoren 2004; Heiss-Harris and Verklan 
2005; Pinnock 1984; Sabon et  al. 1989; Oie and Kamiya 
2005). This difference may be explained by the result of 
Carbone-Traber and Shanks study (Carbone-Traber and 
Shanks 1986), which found that it is important to aspirate 
fluid into a syringe slowly and by a low pressure injection 
method when using not only a filter needle syringe but 
also a side shooting to an infusion set with an in-line filter. 
Our study did not use any specific method to slowly aspi-
rate ampules, and may have used a faster speed of aspira-
tion resulting in increased aspiration pressure compared 
with prior studies. This is an important point, as many 
nurses will be aspirating at a rapid speed in a busy clini-
cal environment. Further research for the optimal speed, 
amount, and pressure of aspiration to minimize particle 
contamination from glass ampules may be needed.
There were ampules with more than 400 glass particles 
in group 1 (immediate aspiration) and group 2 (2  min 
delay), but less than 220 glass particles in all ampules in 
Fig. 3 Box plot of number of glass particles per ampule by group. 
Group 1 Bolus IV after immediate aspiration. Group 2 Bolus IV after 
2 min’ delayed aspiration. Group 3 Bolus IV after aspiration with a 
filter needle syringe. Group 4 Side shooting to an infusion set with an 
in‑line filter
Table 2 Number of ampules by number of glass particles (n = 180)
Group 1 IV bolus injection directly after immediate aspiration, Group 2 IV bolus injection directly after 2 min’ delayed aspiration, Group 3 IV bolus injection directly after 
aspiration with a filter needle syringe and Group 4 Side shooting to an infusion set with an in-line filter
Group Number of glass particles χ2 p
≤50 51–100 101–150 151–200 201–300 >300
1 13 (28.9) 13 (28.9) 6 (13.3) 5 (11.1) 6 (13.3) 2 (4.4) 11.14 0.743
2 12 (26.7) 13 (28.9) 6 (13.3) 7 (15.6) 6 (13.3) 1 (2.2)
3 14 (31.1) 13 (28.9) 4 (8.9) 7 (15.6) 5 (11.1) 2 (4.4)
4 10 (22.2) 19 (42.2) 10 (22.2) 4 (8.9) 2 (4.4) 0 (0.0)
Total 49 (27.2) 58 (32.2) 26 (14.4) 23 (12.8) 19 (10.6) 5 (2.8)
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group 4 (side shooting). This suggests that the contami-
nation of an unusually large number of glass particles 
may be prevented by using an infusion set with an in-line 
filter.
The number of glass particles in group 2 (2 min delay) 
was similar to that of group 1 (immediate aspiration) in 
our research. This may be due to the glass particles set-
tled in the bottom of the ampule being aspirated into 
the syringe because the ampule was inclined during 
aspiration. An ampule contains sufficient drug fluid, so 
it is sometimes recommended not to incline an ampule 
when aspirating the fluid [The Korea Food and Drug 
Administration (KFDA) 2010]. But in clinical practice, 
the ampule is often inverted or tilted sideways with all 
the drug fluid in the ampule being aspirated into the 
syringe to minimize the loss of drug fluid (Craven and 
Hirnle 2009). Therefore, further research to find out how 
much fluid should be aspirated to prevent aspirating 
glass particles settled down on the bottom of the ampule 
is needed. This suggests that further education of nurses 
may be needed to avoid inclining ampules when aspirat-
ing drug fluids.
In this study, the length of the shortest glass particle 
and the longest glass particle was 1.92 and 504.67  µm, 
respectively. The longest glass particle was observed in 
group 1 (immediate aspiration). This can be explained by 
long glass particles in group 2 (2 min delay) settling down 
to the bottom of ampules due to their weight, and fil-
ters in group 3 (filtered needle) and group 4 (side shoot-
ing) filtering out long glass particles. Since the diameter 
of pulmonary vasculature is less than 10  μm, they may 
cause harmful side effects to patients in the medium to 
long term.
The average length of glass particles was the shortest in 
group 2 (2 min delay), but it was statistically insignificant. 
This may be because the long glass particles had time to 
settle down onto the bottom of an ampule due to their 
weight, as stated before. Therefore, to prevent the injec-
tion of abnormally long glass particles into the body, it 
may be useful to utilize natural precipitation by waiting 
a certain period of time before aspirating drug fluid from 
an ampule after opening the ampule. However, further 
research is required to determine whether it is safe to 
Table 3 Length of glass particles (n = 19,473)
Group 1 IV bolus injection directly after immediate aspiration, Group 2 IV bolus 
injection directly after 2 min’ delayed aspiration, Group 3 IV bolus injection 
directly after aspiration with a filter needle syringe and Group 4 Side shooting to 
an infusion set with an in-line filter
Group Length (µm) χ2 p
Mean ± SD Median range
1 (n = 5169) 21.27 ± 18.55 18.06 1.97–504.67 0.826 0.843
2 (n = 5311) 20.87 ± 16.60 17.36 2.11–215.25
3 (n = 4971) 20.97 ± 16.68 17.36 1.92–269.29
4 (n = 4022) 22.70 ± 16.04 20.83 2.39–190.67
Total 21.38 ± 17.06 18.34 1.92–504.67
Fig. 4 Boxplot of length of glass particles by group. Group 1 Bolus 
IV after immediate aspiration. Group 2 Bolus IV after 2 min’ delayed 
aspiration. Group 3 Bolus IV after aspiration with a filter needle syringe. 
Group 4 Side shooting to an infusion set with an in‑line filter
Table 4 Number of glass particles by range of their length (n = 19,473)
Group 1 IV bolus injection directly after immediate aspiration, Group 2 IV bolus injection directly after 2 min’ delayed aspiration, Group 3 IV bolus injection directly after 
aspiration with a filter needle syringe and Group 4 Side shooting to an infusion set with an in-line filter
Group Length of glass particles (μm) χ2 p
≤5 5–10 10–15 15–50 50–100 100–150 150–200 200–300 >300
1 (n = 5169) 390 (7.5) 1167 (22.6) 702 (13.6) 2732 (52.9) 153 (3.0) 17 (0.3) 3 (0.1) 3 (0.1) 2 (0.0) 91.93 0.000
2 (n = 5311) 465 (8.8) 1191 (22.4) 741 (14.0) 2727 (51.3) 166 (3.1) 13 (0.2) 3 (0.1) 5 (0.1) 0 (0.0)
3 (n = 4971) 404 (8.1) 1109 (22.3) 724 (14.6) 2548 (51.3) 164 (3.3) 17 (0.3) 2 (0.0) 3 (0.1) 0 (0.0)
4 (n = 4022) 200 (5.0) 830 (20.6) 533 (13.3) 2278 (56.6) 164 (4.1) 15 (0.4) 2 (0.0) 0 (0.0) 0 (0.0)
Total 1459 (7.5) 4297 (22.1) 2700 (13.9) 10,285 (52.8) 647 (3.3) 62 (0.3) 10 (0.1) 11 (0.1) 2 (0.0)
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wait after opening an ampule in terms of contamination 
control, whether it is possible at busy clinical practice 
situations, and the effectiveness in terms of the number 
of glass particles.
The absolute number of glass particles by their length 
was the smallest in group 4 (side shooting), but the aver-
age length of glass particles was the shortest in group 2 
(2 min delay) among the four groups. No glass particles 
longer than 200  μm were found only in group 4 (side 
shooting). This suggests that the in-line filter effectively 
filtered the injection of very long glass particles.
The significance of this study is that the number and 
the length of glass particles were measured and ana-
lyzed in an injection administration environment similar 
to that of actual clinical practice. In most prior studies, 
glass particles in one or two drops of potentially irregu-
larly distributed fluid of an ampule were measured (Pres-
ton and Hegadoren 2004; Hemingway et al. 2007). In this 
study, the entire drug fluid of an ampule contaminated by 
glass particles during opening was centrifuged to precipi-
tate and a slide was created with sediment (Fig. 5), result-
ing in more glass particles than in prior studies where 
only a small portion of the drug fluid was used.
Although most glass particles were easily observed due 
to their double refraction, small glass particles around 
5  µm in lengths were too small to be analyzed in some 
slides. This may be due to the potential air gaps between 
a slide glass and a cover glass which reduced the clarity 
of the microscope. These slides were re-measured with 
an increased magnification power by using the manually-
adjustable magnifying power capability of the camera. 
Accordingly, ambiguous glass particles in the image of 
initial scanning were reconfirmed by rescanning them 
with a different magnification power. There were a total 
of 10 slides which were re-measured.
Aspiration at a faster rate than prior studies (Carbone-
Traber and Shanks 1986) may have been another factor 
that contributed to the increase in the number of glass 
particles compared to prior studies. In a busy clinical 
practice, aspiration is probably often performed faster 
than what is recommended.
In prior studies, the syringe used was irrigated to 
include the glass particles possibly attached to the syringe 
walls (Carbone-Traber and Shanks 1986; Lee et al. 2011). 
However, in our study, they were excluded since the glass 
particles attached inside of a syringe in clinical practice 
would prevent them from being injected into the patient. 
It is possible that some glass particles may have attached 
and remained in the micropipette tips and microtubes, 
suggesting potential underestimation of glass particles 
in the slides, which suggests the possibility of an even 
greater risk of glass particles in real clinical practice.
Conclusion
Glass particle contamination of an ampule occurred with 
all intravenous injection methods and there are risks of 
harmful side effects to patients due to this contamina-
tion. Although 95 % of glass particles less than 20 μm dis-
appeared within 1 year by becoming dissolved in animal 
clinical studies, it is possible for a large amount of small 
glass particles to accumulate and cause adverse reactions 
(Brewer and Dunning 1947).
This study showed that the 2  min’ delayed aspira-
tion method, which is recommended in the guidelines 
of some countries [The Korea Food and Drug Adminis-
tration (KFDA) 2010], was not effective in reducing the 
injection of the total number of glass particles in clinical 
practice despite preventing the injection of exception-
ally large glass particles. This study suggests that IV bolus 
injection directly after 2 min’ delayed aspiration and filter 
needle syringes, which are frequently recommended to 
minimize contamination, may not be as effective as com-
monly believed, unless they are combined with a slow 
and low pressure aspiration method. A side shooting to 
an infusion set with an in-line filter may prevent injection 
of an irregularly large number of particles and filter out 
Fig. 5 Sampling method. a Prior studies sampled a portion of an 
ampule with irregularly distributed glass particles. b This study used 
the sediment of precipitated particles from a centrifuged ampule 
resulting in sampling of the glass particles of whole ampule
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exceptionally long glass particles from ampules even with 
a faster aspiration speed, but more evidence from a larger 
study is needed.
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